MDL 101731

MDL 101731

A drug of the ribonucleotide diphosphate reductase inhibitor family that is a potent antitumour agent against cultured thyroid cancer cells, induceing apoptosis in tumours with increased Fas expression.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.